Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q13424
UPID:
SNTA1_HUMAN
Alternative names:
59 kDa dystrophin-associated protein A1 acidic component 1; Pro-TGF-alpha cytoplasmic domain-interacting protein 1; Syntrophin-1
Alternative UPACC:
Q13424; A8K7H9; B4DX40; E1P5N1; Q16438
Background:
Alpha-1-syntrophin, known for its alternative names such as 59 kDa dystrophin-associated protein A1 acidic component 1, plays a pivotal role in organizing the subcellular localization of various membrane proteins. It is instrumental in linking receptors to the actin cytoskeleton and the extracellular matrix through the dystrophin glycoprotein complex, crucial for synapse formation and neuromuscular synapse organization.
Therapeutic significance:
Alpha-1-syntrophin's involvement in Long QT syndrome 12, a heart disorder leading to sudden death, underscores its potential as a target for therapeutic intervention. Understanding its role could pave the way for innovative treatments for this and possibly other related cardiac conditions.